Aerobe provides cutting-edge technology and scientific expertise to support researchers and clinicians in their endeavour to find novel approaches and innovative solutions in a range of disciplines.
We are a goal focused and process driven company, helping us command a high level of professional reputation and goodwill with all our stakeholders.
The LiveAmp is a wearable, 24-bit amplifier – available with 8, 16, 32 and also with 64 channels. As it is wireless and allows you to store your recorded data internally (i.e. on an exchangeable memory card), there are no mobility limitations.
Transcranial Pulse Stimulation (TPS) is a revolutionary new technique that delivers short acoustic pulses with an ultrasound frequency range. The technique allows unprecedented focal brain stimulation reaching depths of as much as 8 cm in the brain. Developed by Storz Medical, the system (NEUROLITH ®) reflects a unparalleled advancement in the field of transcranial stimulation.
The NIRSport 2 is a user-friendly, modular, and robust wireless functional near-infrared spectroscopy (fNIRS) platform which measures hemodynamic responses to neuroactivation via oxy-, deoxy-, and total hemoglobin changes in the cerebral cortex.
The NIRSport 2 comes with a host of ready-to-implement upgrades and modules to meet the needs of a broad range of cognitive neuroscience applications.
The CXS sensor unit (CODA unit) is capable of operating in bright sunlight up to 90,000 Lux.
The CXS combines three motion sensing arrays into one unit. This allows a standalone CXS unit to make a complete 3D measurement without reference to any other units. It also means that the unit can be pre-calibrated and sealed. All the user does is to point the unit at the action.
Designed with user workflow and IT standards in mind, the MYOQUICK EMG-EP system features a color coded Human Interface Device, programmable foot pedal and active handheld stimulator that maximizes efficiency and increases patient comfort.
The Soterix Medical 1×1 was developed by clinical researchers, scientists, and biomedical engineers to provide all clinical standard tDCS protocols. Current intensity from 0.1 to 2 mA (5 mA option available upon request), and current duration from 5 to 40 minutes. Stimulation set-up is straight-forward with the simple to set-up Open-Panel™ controls, 1×1 electrode accessories, and SmartScan™ indicator. The tDCS 1×1 features allow you to focus on the subject and experiment, not the device.
Medoc Q-Sense is a portable, easy-to-use and affordable quantitative sensory testing (QST) device for clinical, research and pharmacologic trial use.
Q-Sense offers scientifically validated measures of warm, cool and heat-pain thermal sensory thresholds. All of these can be useful determinants in the evaluation of peripheral sensory nerve function, neuropathic pain, diabetic, chemotherapeutic, and other small-fiber neuropathies.
The EyeBrain T2 is a medical device measuring eye and head movements.
It was designed to assist in the diagnosis of neurological and psychiatric diseases and reading disorders.
Severals test are available to assess parameters as latency, speed and precision during saccads.
The EyeBrain Trackers innovate by enabling patient test results to be compared to normative values in the same way as a blood test.
With its slim design, high definition 40” display and superior picture quality, the InroomViewingDevice is the optimal choice for an easy-to-use alternative to conventional projectors or goggle-based image delivery systems.
This is the ideal tool to provide images or video inside the MRI scan room.
We are committed to provide the best Customer Support in the Industry. A sale is not an end, rather it is a beginning of a relationship for Aerobe. We believe that a satisfied customer is the best Sales reference.
Facts about us-
Alzheimer”s disease (AD) is considered to be a progressive irreversible illness. So far an effective treatment of symptoms in Alzheimer”s disease has not yet been found. One of the symptoms often found in AD patients is the significant reduction of executive functions. Furthermore” affective fluctuations and depressive moods occur regularly. Transcranial pulse stimulation (TPS) induced by shock waves which were individually navigated according to current MRI-scans induced an amelioration of executive functions and reductions of depressive symptoms in patients with AD.
Alzheimer’s disease (AD) is a very common cause of dementia in many countries all over the world and a common cause of death in elderly humans. No effective long-term treatment has been found yet. TPS (Transcranial Pulse Stimulation), which can be individually tracked by MRT-scans, offers new perspectives to ameliorate deficits caused by AD. Pilot studies show beneficial effects on learning and memory of TPS. There are also reports of restorative structural changes in the thickness of the cerebral cortex due to the stimulation.
The Dementia syndrome is understood as being a disturbance of various cognitive functions, e.g. memory and orientation, over and above the average of those commonly experienced in old age. There are often pronounced deficits in social and employment everyday behaviour [1]. Primary and secondary dementia categories are recognized clinically: primary - the responsible alterations are to be found in the brain. Secondary - another illness of an organ apart from the brain is responsible [2]. Dementia is one of the most common psychiatric diseases in old age and dementia is very often first recognized at a late stage [1, 2]
Transcranial Pulse Stimulation (TPS) is a new non-invasive neuromodulation therapy that uses shockwaves for the treatment of Alzheimer´s Disease (AD). Recently, our group published short term clinical results after the first treatment cycle of 2 weeks (Cont et al., 2022). We found a significant improvement in the Alzheimer Disease Assessment Scale (ADAS) and in affective scores. Yet, no long-term results have been reported. Here we show first results after one stimulation cycle, 3 months, 6 months and up to 12 months.
In this two-day workshop in Singapore we will give an introduction to EEG analysis methods using Analyzer 2. The workshop will give a comprehensive introduction to the Analyzer 2 software followed by lectures and hands-on data analysis sessions covering data processing steps such as preprocessing, artifact handling, event related potential analysis, and spectral analysis. This event is intended for researchers who are new to EEG & Analyzer 2 as well as more experienced researchers looking for useful tips.
The first day will cover the nature of the EEG signal, how to acquire an EEG signal, and how to optimize your recording setup. Then, days 2-4 will focus on EEG analysis with BrainVision Analyzer. We will cover all major EEG analysis methods in Analyzer. Learn more and get your tickets to this in-person hands-on workshop.
An increasing number of research applications require online access to EEG data streams. For example, when signal features of the EEG are used to trigger TMS (Transcranial Magnetic Stimulation) pulses, or where algorithms in BCI (Brain Computer Interface) applications are used to provide immediate response. For these applications, minimum latency and high accuracy become increasingly important.
Transcranial pulse stimulation (TPS) is a recent development in non-invasive brain stimulations (NIBS) that has been proven to be effective in terms of significantly improving Alzheimer patients’ cognition, memory, and execution functions. Nonetheless, there is, currently, no trial evaluating the efficacy of TPS on adults with major depression disorder (MDD) nationwide. In this single-blinded, randomized controlled trial, a 2-week TPS treatment comprising six 30 min TPS sessions were administered to participants. Participants were randomized into either the TPS group or the Waitlist Control (WC) group, stratified by gender and age according to a 1:1 ratio.
The first association one makes with the Wireless Trigger system is that it can be used to send triggers without the need for cables and a bulky setup. This already gives you a lot of freedom when planning an experiment with LiveAmps where movement should not be restricted or where additional cables would compromise the experience of the participants.
Brain-Computer Interface (BCI) systems for motor rehabilitation after stroke have proven their efficacy to enhance upper limb motor recovery by reinforcing motor related brain activity. Hybrid BCIs (h-BCIs) exploit both central and peripheral activation and are frequently used in assistive BCIs to improve classification performances. However, in a rehabilitative context, brain and muscular features should be extracted to promote a favorable motor outcome, reinforcing not only the volitional control in the central motor system, but also the effective projection of motor commands to target muscles, i.e., central-to-peripheral communication.
Stroke is a leading cause of adult disability in the United States. High doses of repeated task-specific practice have shown promising results in restoring upper limb function in chronic stroke. However, it is currently challenging to provide such doses in clinical practice. At-home telerehabilitation supervised by a clinician is a potential solution to provide higher-dose interventions. However, telerehabilitation systems developed for repeated task-specific practice typically require a minimum level of active movement. Therefore, severely impaired people necessitate alternative therapeutic approaches.
Te human brain dynamically engages distinct neural populations between distant brain regions, and their spatiotemporal oscillations often modulate systematically with behavioral and cognitive tasks. The synchrony or lack thereof between remote brain regions brings efective global brain communication, functional connectivity for information processing.
An increasing number of research applications require online access to EEG data streams. For example, when signal features of the EEG are used to trigger TMS (Transcranial Magnetic Stimulation) pulses, or where algorithms in BCI (Brain Computer Interface) applications are used to provide immediate response. For these applications, minimum latency and high accuracy become increasingly important.
The first association one makes with the Wireless Trigger system is that it can be used to send triggers without the need for cables and a bulky setup. This already gives you a lot of freedom when planning an experiment with LiveAmps where movement should not be restricted or where additional cables would compromise the experience of the participants.
Brain-Computer Interface (BCI) systems for motor rehabilitation after stroke have proven their efficacy to enhance upper limb motor recovery by reinforcing motor related brain activity. Hybrid BCIs (h-BCIs) exploit both central and peripheral activation and are frequently used in assistive BCIs to improve classification performances. However, in a rehabilitative context, brain and muscular features should be extracted to promote a favorable motor outcome, reinforcing not only the volitional control in the central motor system, but also the effective projection of motor commands to target muscles, i.e., central-to-peripheral communication.
It has been designed with a new REVERSE layout to meet the requirements coming from the market where the reverse layout is required and can be used for clinical routine EEG in wireless modein combination with SD LTM PLUS amplifier.
We are happy to announce the new SyncBox Scanner Interface Duo. The SyncBox is used to synchronize the sampling rate of the BrainAmp MR amplifier with the MR scanner clock system. In brief, the aim is to achieve phase locking between the two clock systems to facilitate optimum correction of scanner-related artifacts in the EEG data. This is essential for achieving the best EEG-fMRI data quality. The SyncBox system comprises the SyncBox Main Unit and the SyncBox Scanner Interface. The Main Unit distributes the sync signal to the BrainAmp USB 2 Adapter (BUA), which drives the sampling frequency, and also to the computer to allow online synchronization validation. Whereas, the Scanner Interface galvanically isolates the Main Unit from the MR scanner to prevent any impact on the scanner clock system.
Hyperscanning research has been developed to study the brain in a social environment. The interactive and social nature of the human brain is largely omitted in conventional paradigms. This is a crucial limitation for research subjects such as social behavior, interpersonal coordination, interactive decision-making, or affective communication.
In this two-day workshop in Singapore we will give an introduction to EEG analysis methods using Analyzer 2. The workshop will give a comprehensive introduction to the Analyzer 2 software followed by lectures and hands-on data analysis sessions covering data processing steps such as preprocessing, artifact handling, event related potential analysis, and spectral analysis. This event is intended for researchers who are new to EEG & Analyzer 2 as well as more experienced researchers looking for useful tips.
The first day will cover the nature of the EEG signal, how to acquire an EEG signal, and how to optimize your recording setup. Then, days 2-4 will focus on EEG analysis with BrainVision Analyzer. We will cover all major EEG analysis methods in Analyzer. Learn more and get your tickets to this in-person hands-on workshop.
CoVAS (Computerized Visual Analogue Scale) is a hardware accessory for use with the Pathway ATS and CHEPS, TSA2, Q-Sense, and AlgoMed systems. CoVAS offers computerized, real-time, continuous VAS evaluation – adding an important dimension to stimulus intensity measurements. In this short webinar we will go into the different applications of the COVAS device through examples of use in the software and some research publications in which the COVAS was used.
Alzheimer”s disease (AD) is considered to be a progressive irreversible illness. So far an effective treatment of symptoms in Alzheimer”s disease has not yet been found. One of the symptoms often found in AD patients is the significant reduction of executive functions. Furthermore” affective fluctuations and depressive moods occur regularly. Transcranial pulse stimulation (TPS) induced by shock waves which were individually navigated according to current MRI-scans induced an amelioration of executive functions and reductions of depressive symptoms in patients with AD.
Alzheimer’s disease (AD) is a very common cause of dementia in many countries all over the world and a common cause of death in elderly humans. No effective long-term treatment has been found yet. TPS (Transcranial Pulse Stimulation), which can be individually tracked by MRT-scans, offers new perspectives to ameliorate deficits caused by AD. Pilot studies show beneficial effects on learning and memory of TPS. There are also reports of restorative structural changes in the thickness of the cerebral cortex due to the stimulation.
The Dementia syndrome is understood as being a disturbance of various cognitive functions, e.g. memory and orientation, over and above the average of those commonly experienced in old age. There are often pronounced deficits in social and employment everyday behaviour [1]. Primary and secondary dementia categories are recognized clinically: primary - the responsible alterations are to be found in the brain. Secondary - another illness of an organ apart from the brain is responsible [2]. Dementia is one of the most common psychiatric diseases in old age and dementia is very often first recognized at a late stage [1, 2]
We provide solutions for healthcare and research. We distribute medical equipment, provide scientific expertise and support to researcher
© 2020 Aerobe. All Rights Reserved Terms & Conditions | Privacy Policy